Drugs / rATG
last change Oct 2021 re-read 3 minutes ago

rATG

Protein / enzyme biologic

Developed for
acute transplant rejection
Investigated by
The Methodist Hospital Research Institute

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02102854 Mar 2014 → Mar 2021 acute transplant rejection The Methodist Hospital Research Institute Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rATG ClinicalTrials.gov intervention name — accepted as the source's own label NCT02102854 ↗
Modality Protein / enzyme biologic “horse or rabbit-derived antibodies against human T cells” NCT02102854 ↗